Benutzerspezifische Werkzeuge

Publikationen

Ausgewählte Publikationen der letzten Jahre

2018

2017

  • Günther R , Balck A, Koch JC, Nientiedt T, Sereda M, Bähr M, Lingor P, Tönges L. Rho Kinase Inhibition with Fasudil in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis-Symptomatic Treatment Potential after Disease Onset. Front Pharmacol. 2017 Jan 31;8:17. doi: 10.3389/fphar.2017.00017.

  • Linse K, Rüger W, Joos M, Schmitz-Peiffer H, Storch A, Hermann A . Eyetracking-based assessment suggests preserved wellbeing in locked-in patients. Ann Neurol. 2017 Jan 11. doi: 10.1002/ana.24871 (IF: 9.638)

2016

  • Stanslowsky N*, Reinhardt P*, Glass H , Kalmbach N, Naujock M, Lübben V, Hensel N, Pal A , Venneri A, De Franceschi L, Claus P, Sterneckert J, Storch A, Hermann A *, Wegner F*. Neuronal dysfunction in iPSC-derived medium spiny neurons from Chorea-Acanthocytosis patients is reversed by Src kinase inhibition and F-actin stabilization, J Neurosci, 2016 Nov 23;36(47):12027-12043.

  • Sivadasan R, Hornburg D, Drepper C, Frank N, Jablonka S, Hansel AA, Hermann A , Lojewski X; Sterneckert J, Shaw P, Ince P, Mann M, Meissner F, Sendtner M. C9ORF72 interaction with cofilin modulates actin dynamics in motoneurons. Nat. Neurosci, 2016; Dec;19(12):1610-1618

  • Lupo F, Tibaldi E, Matte A, Sharma AK, Brunati AM, Alper SL, Zancanaro C, Benati D, Siciliano A, Bertoldi M, Zonti F, Storch A, Walker RH, Danek A, Bader B, Hermann A , De Franceschi L. Impaired autophagy is involved in abnormalities of erythroid cells from patients with chorea-acanthocytosis. Blood, 2016 Dec 22;128(25):2976-2987.

  • Loewenbrück, K. F., Dittrich, M., Böhm, J., Klingelhöfer, J., Baum, P., Schäfer, J., ... & Storch, A. (2016). Diagnostic accuracy of nerve ultrasound in hereditary and sporadic non-entrapment neuropathies. Journal of neurology , 263 (11), 2196-2206.

  • Loewenbrück, K. F., Wach, D., Müller, S. R., Youngner, S. J., & Burant, C. J. (2016). Disclosure of adverse outcomes in medicine: A questionnaire study on voice intention and behaviour of physicians in Germany, Japan and the USA. German Journal of Human Resource Management , 30 (3-4), 310-337.

  • Lars P. Pallesen , Andrei Khomenko, Imanuel Dzialowski, Jessica Barlinn, Kristian Barlinn, Charlotte Zerna , Erik J.R.J. van der Hoeven, Ale Algra, L. Jaap Kapelle, Patrik Michel, Ulf Bodechtel , Andrew M. Demchuk, Wouter Schonewille, Volker Puetz ; on behalf of the BASICS-Study group. CT-Angiography source images indicate less fatal outcome despite coma of patients in the Basilar Artery International Cooperation Study (BASICS). Int J Stroke, in press (2016) (IF: 3,044)
  • van der Hoeven EJ, McVerry F, Vos JA, Algra A, Puetz V , Kappelle LJ, Schonewille WJ; BASICS registry investigators.Collateral flow predicts outcome after basilar artery occlusion: The posterior circulation collateral score. Int J Stroke. 2016 Oct;11(7):768-75 (IF: 3,044)
  • Von der Hagen M., Bodechtel U., Pütz V ., Hahn G., Hedrich C.M., Brenner S., Linn J., Knöfler R. Schlaganfall im Kindesalter. Pädiatrische Praxis 2016; 86(1):55-68 (IF: 0, )
  • Mückschel M , Beste C, Ziemssen T . Immunomodulatory treatments and cognition in MS. Acta Neurol Scand. 2016 Sep;134 Suppl 200:55-9.
  • Zerna C , Kamal N, Lindsay MP, Fang J, Hill MD. The impact of transferring stroke patients: An analysis of national administrative data. Can J Neurol Sci. 2016 Sep 13:1-5. [Epub ahead of print] (IF 0.61)
  • Kappos L, Li DK, Stüve O, Hartung HP, Freedman MS, Hemmer B, Rieckmann P, Montalban X, Ziemssen T , Hunter B, Arnould S, Wallström E, Selmaj K. Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study. JAMA Neurol. 2016 Sep 1;73(9):1089-98. doi: 10.1001/jamaneurol.2016.1451. PubMed PMID: 27380540.
  • Sands KA, Shahripour RB, Kumar G, Barlinn K , Lyerly MJ, Haršány M, Cure J, Yakov YL, Alexandrov AW, Alexandrov AV. Acute Isolated Central Facial Palsy as Manifestation of Middle Cerebral Artery Ischemia. J Neuroimaging. 2016 Sep;26(5):499-502. (IF: 1,625)
  • Barlinn J, Barlinn K , Helbig U, Siepmann T, Pallesen LP , Urban H, Pütz V, Schmitt J, Reichmann H, Bodechtel U. Organized Post-Stroke Care through Case Management on the Basis of a Standardized Treatment Pathway : Results of a Single-Centre Pilot Study. Nervenarzt. 2016 Aug;87(8):860-9 (IF: 0,806)
  • Chmielewski WX, Mückschel M , Ziemssen T , Beste C. The norepinephrine system affects specific neurophysiological subprocesses in the modulation of inhibitory control by working memory demands. Hum Brain Mapp. 2016 Aug 13. doi: 10.1002/hbm.23344.
  • Ziemssen T , Kern R , Cornelissen C. Study design of PANGAEA 2.0, anon-interventional study on RRMS patients to be switched to fingolimod. BMC Neurol. 2016 Aug 8;16:129.
  • Ziemssen T , Kern R, Thomas K . Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach. BMC Neurol. 2016 Aug 2;16:124.
  • Schrempf W , Katona I, Dogan I, Felbert VV, Wienecke M, Heller J, Maier A, Hermann A, Linse K, Brandt MD, Reichmann H , Schulz JB, Schiefer J, Oertel WH, Storch A , Weis J, Reetz K. Reduced intraepidermal nerve fiber density in patients with REM sleep behavior disorder. Parkinsonism Relat Disord. 2016 Aug; 29:10-6 (IF: 3.794)
  • Siepmann T, Frenz E, Penzlin AI, Goelz S, Zago W, Friehs I, Kubasch ML, Wienecke M, Löhle M, Schrempf W, Barlinn K, Siegert J, Storch A, Reichmann H, Illigens BM. Pilomotor function is impaired in patients with Parkinson's disease: A study of the adrenergic axon-reflex response and autonomic functions. Parkinsonism Relat Disord. 2016 Aug 11. [Epub ahead of print] (IF: 3,794)
  • Mengel D, Dams J, Ziemek J, Becker J, Balzer-Geldsetzer M, Hilker R , Baudrexel S, Kalbe E,Schmidt N, Witt K, Liepelt-Scarfone I,  Graeber S, Petrelli A, Neuser P, Schulte C, Linse K, Storch A ,Wittchen H-U, Riedel O, Mollenhauer B, Ebentheuer J, Trenkwalder C, Klockgether T, Spottke A, Wüllner U, Schulz J B, Reetz K, Heber I A , Ramirez A, Dodel R.  Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease. Parkinsonism and Related Disorders. 2016 Aug; 29: 112-116
  • Reichmann H, Brandt MD, Klingelhöfer L . The non-motor features of Parkinson’s disease: pathophysiology and management advances. Curr Opin Neurol.  2016 Aug; 29(4): 467-73 (IF: 4.469)
  • Overall RW, Walker T, Fischer T, Brandt MD , Kempermann G. Different mechanisms must be considered to explain the increase in hippocampal neural precursor cell proliferation by physical activity. Front Neurosci 2016 Aug (IF: 3.398)
  • Kepplinger J, Barlinn K, Deckert S, Scheibe M, Bodechtel U, Schmitt J. Safety and efficacy of thrombolysis in telestroke: A systematic review and meta-analysis. Neurology. 2016 Aug 26. [Epub ahead of print] (IF: 8,116)
  • Zerna C , Modi J, Bilston L, Shoamanesh A, Coutts SB, Smith EE. Cerebral Microbleeds and Cortical Superficial Siderosis in Patients Presenting with Minor Cerebrovascular Events. Stroke 2016; doi:10.1161/STROKEAHA.116.013418. Epub 2016 Aug 9. (IF 5.787)
  • Hermann A , Kim JB, Srimasorn S , Zaehres H, Reinhardt P, Schöler HR, Storch A . Factor-Reduced Human Induced Pluripotent Stem Cells Efficiently Differentiate into Neurons Independent of the Number of Reprogramming Factors. Stem Cells Int. 2016;2016:4736159. (IF: 3,687)
  • Ziemssen T , Engelmann U, Jahn S, Leptich A, Kern R, Hassoun L, Thomas K . Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS). BMC Neurol. 2016 Jul 19;16:109.
  • Ziemssen T , Gass A, Wuerfel J, Bayas A, Tackenberg B, Limmroth V, Linker R, Mäurer M, Haas J, Stangel M, Meergans M, Harlin O, Hartung HP. Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab. BMC Neurol. 2016 Jul 12;16:98.
  • Ziemssen T , Phillips G, Shah R, Mathias A, Foley C, Coon C, Sen R, Lee A, Agarwal S. Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ). J Neurol. 2016 Oct;263(10):1969-83. doi: 10.1007/s00415-016-8210-4. Epub 2016 Jul 8. PubMed PMID: 27393117.
  • Martin KD, Polanski WH, Schulz AK, Jöbges M, Ziemssen T , Schackert G, Pinzer  T, Sobottka SB. ActiGait implantable drop foot stimulator in multiple sclerosis: a new indication. J Neurosurg. 2016 Jul 1:1-6. [Epub ahead of print] PubMed
  • Haase R , Kullmann JS, Ziemssen T . Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey. TherAdv Neurol Disord. 2016 Jul;9(4):250-63.
  • Mori K, Nihei Y, Arzberger T, Zhou Q, Mackenzie IR, Hermann A , Hanisch F; German Consortium for Frontotemporal Lobar Degeneration; Bavarian Brain Banking Alliance, Kamp F, Nuscher B, Orozco D, Edbauer D, Haass C. Reduced hnRNPA3 increases C9orf72 repeat RNA levels and dipeptide-repeat protein deposition. EMBO Rep. 2016 Jul 26. pii: e201541724. (IF: 7,7)
  • Kalbe E, Rehberg S, Heber I A, Kronenbuerger M, Schulz J B, Storch A, Linse K, Schneider C , Gräber S, Liepelt-Scarfone I,  Berg D, Dams J,Balzer-Geldsetzer M, Hilker R, Oberschmidt C, Witt K, Schmidt N, Mollenhauer B, Trenkwalder C, Spottke A, Roeske S, Wittchen H-U, Riedel O, Dodel R. Subtypes of mild cognitive impairment in patients with Parkinson’s disease: evidence from the LANDSCAPE study. Journal of Neurology, Neurosurgery and Psychiatry. 2016, Published Online First: July 8 2016; doi:10.1136/jnnp2016-313838
  • Toutouna L, Nikolakopoulou P, Poser SW, Masjkur J, Arps-Forker C, Troullinaki M, Grossklaus S, Bosak V, Friedrich U, Ziemssen T , Bornstein SR, Chavakis T, Androutsellis-Theotokis A. Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination. Brain Res. 2016 Jul 1;1642:124-30.
  • Günther R, Richter N , Sauerbier A, Chaudhuri KR, Martinez-Martin P, Storch A, Hermann A . Non-Motor Symptoms in Patients Suffering from Motor Neuron Diseases. Front Neurol. 2016 Jul 25;7:117. (IF: 3,184)
  • Appireddy R, Zerna C , Menon BK, Goyal M. Endovascular Interventions in Acute Ischemic Stroke: Recent Evidence, Current Challenges, and Future Prospects. Curr Atheroscler Rep. 2016 Jul;18(7):40. doi: 10.1007/s11883-016-0588-z. Review. (IF 3.006)
  • Zerna C, Guenther M, Folprecht G, Puetz V . Acute ischaemic stroke and myocardial infarction after chemotherapy with vinorelbine for non-small cell lung cancer: a case report. J Chemother. 2016 Jul 22:1-5 (IF: 1,333)
  • Gerber J, Puetz V, Bodechtel U, Kitzler H, von Kummer R, Linn J.Endovascular treatment of ischaemic stroke patients - new evidence and old challenges. Vasa. 2016;45(4):267-74 (IF: 1,122)
  • Case NF, Charlton A, Zwiers A, Batool S, McCreary CR, Hogan DB, Ismail Z, Zerna C , Coutts SB, Frayne R, Goodyear B, Haffenden A, Smith EE. Cerebral Amyloid Angiopathy is Associated with Executive Dysfunction and Mild Cogntitive Impairment. Stroke. 2016 Jun 23. pii: STROKEAHA.116.012999. Epub 2016 Jun 23. (IF 5.787)
  • Spieth PM, Kubasch AS, Penzlin AI, Illigens BM, Barlinn K, Siepmann T . Randomized controlled trials - a matter of design. Neuropsychiatr Dis Treat. 2016 Jun 10;12:1341-9. (IF: 1,876)
  • Yu AY, Zerna C , Aziz Z, Holodinsky JK, Randhawa PA, Najm M, Goyal M, Menon BK, Demchuk AM, Coutts SB, Hill MD. Multiphase CT angiography increases detection of intracranial occlusion in acute ischemic stroke. Neurology. 2016 Jul 6. pii: 10.1212/WNL.0000000000002951. Epub 2016 Jul 6. (IF 8.166)
  • Gerber JC, Petrova M, Krukowski P, Kuhn M, Abramyuk A, Bodechtel U, Dzialowski I, Engellandt K, Kitzler H, Pallesen LP, Schneider H, von Kummer R, Puetz V, Linn J. Collateral state and the effect of endovascular reperfusion therapy on clinical outcome in ischemic stroke patients. BrainBehav. 2016 Jun 17 (IF 2,218)
  • Schrempf W , Katona I, Dogan I, Felbert VV, Wienecke M , Heller J, Maier A, Hermann A , Linse K, Brandt MD, Reichmann H , Schulz JB, Schiefer J, Oertel WH, Storch A , Weis J, Reetz K. Reduced intraepidermal nerve fiber density in patients with REM sleep behavior disorder. Parkinsonism Relat Disord. 2016 Jun 6. pii: S1353-8020(16)30199-7. (IF: 3,794)
  • Naujock M, Stanslowsky N, Bufler S, Naumann M, Reinhardt P, Sterneckert J, Kefalakes E, Kassebaum C, Bursch F, Lojewski X, Storch A , Frickenhaus M, Boeckers TM, Putz S, Demstre M, Liebau S, Klingenstein M, Ludolph AC, Dengler R, Kim KS, Hermann A , Wegner F*, Petri S*. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from ALS Patient-Derived Induced Pluripotent Stem Cells. Stem Cells. 2016 Jun;34(6):1563-75 (IF 5.902) *Contributed equally
  • Navalkele DD, Barlinn K , Minagar A, Chernyshev OY. Exploration of screening practices for obstructive sleep apnea in stroke medical community: A pilot study. Pathophysiology. 2016 Jun;23(2):105-9. (IF: 0,693)
  • Zerna C , Assis Z, d’Esterre CD, Menon BK, Goyal M. Imaging, Intervention, and Workflow in Acute Ischemic Stroke: The Calgary Approach. AJNR Am J Neuroradiol. 2016 Jun;37(6):978-84. (IF 3.124)
  • Ziemssen T , Derfuss T, de Stefano N, Giovannoni G, Palavra F, Tomic D, Vollmer T, Schippling S. Optimizing treatment success in multiple sclerosis. J Neurol. 2016 Jun;263(6):1053-65.
  • Klotz L, Berthele A, Brück W, Chan A, Flachenecker P, Gold R, Haghikia A, Hellwig K, Hemmer B, Hohlfeld R, Korn T, Kümpfel T, Lang M, Limmroth V, Linker RA, Meier U, Meuth SG, Paul F, Salmen A, Stangel M, Tackenberg B, Tumani H, Warnke C, Weber MS, Ziemssen T , Zipp F, Wiendl H. [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Nervenarzt. 2016 Jun;87(6):645-59.
  • Sehr T, Proschmann U, Thomas K, Marggraf M , Straube E, Reichmann H , Chan A, Ziemssen T . New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained fromclinical and in vitro studies. J Neuroinflammation. 2016 Jun 27;13(1):164.
  • Hainke U, Thomas K, Ziemssen T . Laquinimod in the treatment of relapsing remitting multiple sclerosis. Expert Opin Drug Metab Toxicol. 2016 Jun;12(6):701-9.
  • Barlinn K, Floegel T, Kitzler HH , Kepplinger J, Siepmann T, Pallesen LP , Bodechtel U, Reichmann H, Alexandrov AV, Puetz V . Multi-parametric ultrasound criteria for internal carotid artery disease-comparison with CT angiography. Neuroradiology. 2016 May 26. [Epub ahead of print] (IF: 2,485)
  • Yu AY, Holodinsky JK, Zerna C , Svenson LW, Jettè N, Quan H, Hill MD. Use and Utility of Administrative Health Data for Stroke Research and Surveillance. Stroke. 2016 Jul;47(7):1946-52. doi: 10.1161/STROKEAHA.116.012390. Epub 2016 May 12. (IF 5.787)
  • Mückschel M, Smitka M, Hermann A , von der Hagen M, Beste C. Deep brain stimulation in the globus pallidus compensates response inhibition deficits: evidence from pantothenate kinase-associated neurodegeneration. Brain Struct Funct. 2016 May, 221(4):2251-7 (IF 5,618).
  • Kretner B*, Trambauer J*, Fukumori A, Mielke J, Kuhn PH, Kremmer E, Giese A, Lichtenthaler SF, Haass C, Arzberger T, Steiner H. Generation and deposition of Aβ43 by the virtually inactive presenilin-1 L435F mutant contradicts the presenilin loss-of-function hypothesis of Alzheimer's disease. EMBO Mol Med. 2016 May 2;8(5):458-65 (IF 9,547) *contributed equally
  • Hainke U, Thomas K, Ziemssen T . Laquinimod in the treatment of relapsing remitting multiple sclerosis. Expert Opin Drug Metab Toxicol. 2016 Jun;12(6):701-9. doi: 10.1080/17425255.2016.1179279. Epub 2016 May 2
  • Ziemssen T , Hillert J, Butzkueven H. The importance of collecting structured clinical information on multiple sclerosis. BMC Med. 2016 May 31;14:81.
  • Viehweg J, Reimann M, Gasch J, Rüdiger H, Ziemssen T . Comparison of baroreflex sensitivity estimated from ECG R-R and inter-systolic intervals obtained by finger plethysmography and radial tonometry. J Neural Transm (Vienna). 2016 May;123(5):481-90.
  • Gross CC, Schulte-Mecklenbeck A, Rünzi A, Kuhlmann T, Posevitz-Fejfár A, Schwab N, Schneider-Hohendorf T, Herich S, Held K, Konjević M, Hartwig M, Dornmair K, Hohlfeld R, Ziemssen T , Klotz L, Meuth SG, Wiendl H. Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation. Proc Natl Acad Sci U S A. 2016 May 24;113(21):E2973-82.
  • Vercruysse P, Sinniger J, El Oussini H, Scekic-Zahirovic J, Dieterlé S, Dengler R, Meyer T, Zierz S, Kassubek J, Fischer W, Dreyhaupt J, Grehl T, Hermann A , Grosskreutz J, Witting A, Van Den Bosch L, Spreux-Varoquaux O; GERP ALS Study Group, Ludolph AC, Dupuis L. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain. 2016 Apr;139(Pt 4):1106-22. (IF: 10,103)
  • Ziemssen T , Calabrese P, Penner IK, Apfel R. QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients. J Neurol. 2016 Apr;263(4):784-91.
  • Bodechtel U, Barlinn K, Helbig U, Arnold K, Siepmann T , Pallesen LP , Puetz V, Reichmann H, Schmitt J, Kepplinger J. The stroke east Saxony pilot project for organized post-stroke care: a case-control study. Brain Behav. 2016 Apr 28;6(5):e00455 (IF 2,218)
  • Pallesen LP , Ragaller M , Kepplinger J, Barlinn K, Zerna C, Siepmann T, Wiedemann B, Braun S, Weise M, Bodechtel U, Puetz V . Diagnostic Impact of Transesophageal Echocardiography in Patients with Acute Cerebral Ischemia. Echocardiography. 2016 Apr;33(4):555-61 (IF: 1,432)
  • Zerna C , Hegedus J, Hill MD. Evolving Treatments of Acute Ischemic Stroke. Circ Res. 2016 Apr 29;118(9):1425-42. doi: 10.1161/CIRCRESAHA.116.307005. (IF 11.551)
  • Thomas K, Eisele J, Rodriguez-Leal FA, Hainke U, Ziemssen T . Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2016 Apr 29;3(3):e228.
  • Schönenberger S, Niesen WD, Fuhrer H, Bauza C, Klose C, Kieser M, Suarez JI, Seder DB, Bösel J; SETPOINT2-Study Group; IGNITE-Study Group ( Schneider H ). Early tracheostomy in ventilated stroke patients: Study protocol of the international multicenter randomized trial SETPOINT2 (Stroke-related Early Tracheostomy vs. Prolonged Orotracheal Intubation in Neurocritical care Trial 2). Int J Stroke . 2016 Apr;11(3):368-79. (IF: 3.044)
  • Untucht R, Reif A. Successful treatment of an adult with symptomatic attention deficit, hyperactivity, and impulsivity after temporal lobe resection: case report. Atten Defic Hyperact Disord 2016 Mar;8(1):59-62
  • Woopen H, Richter R, Ismaeel F, Chekerov R, Roots I, Siepmann T , Sehouli J. The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancer. Gynecol Oncol 2016 Mar;140(3):554-558. (IF 3,77)
  • Nassir M, Guan J, Luketina H, Siepmann T , Rohr I, Richter R, Castillo-Tong DC, Zeillinger R, Vergote I, Van Nieuwenhuysen E, Concin N, Marth C, Hall C, Mahner S, Woelber L, Sehouli J, Braicu EI. The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study. Tumour Biol 2016 Mar;37(3):3009-3016. (IF 2,93)
  • Lohkamp L, Öllinger R, Chatzigeorgiou A, Illigens BM, Siepmann T . Intraoperative biomarkers in renal transplantation. Nephrology (Carlton). 2016 Mar;21(3):188-199. (IF 1,80)
  • Kowoll CM, Kaminski J, Weiß V, Bösel J, Dietrich W, Jüttler E, Flechsenhar J, Guenther A, Huttner HB, Niesen WD, Pfefferkorn T, Schirotzek I, Schneider H , Liebig T, Dohmen C. Severe Cerebral Venous and Sinus Thrombosis: Clinical Course, Imaging Correlates, and Prognosis. Neurocrit Care . 2016 Mar 21. [Epub ahead of print] (IF: 2.488)
  • Hübers A, Hildebrandt V, Petri S, Kollewe K, Hermann A , Storch A , Hanisch F, Zierz S, Rosenbohm A, Ludolph AC, Dorst J. Clinical features and differential diagnosis of flail arm syndrome. J Neurol. 2016 Feb;263(2):390-5 (IF 3.377)
  • Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, […] Barlinn K , Pallesen LP , Kepplinger J, Bodechtel U , Gerber J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Lees KR. Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study. J Neurol. 2016 Feb;263(2):231-7. (IF 3,408)
  • Raspe M, Müller-Marbach A, Schneider M, Siepmann T , Schulte K. Work and training conditions of young German physicians in internal medicine. Results of a nationwide survey by young internists from the German Society of Internal Medicine and the German Professional Association of Internists. Dtsch Med Wochenschr 2016 Feb;141(3):202-210 (IF 0,50)
  • Klourfeld E, Zerna C , Al-Ajlan FS, Kamal N, Randhawa P, Yu AY, Dowlatshani D, Thornton J, Williams D, Holmstedt C, Kelly M, Frei D, Baxter B, Linares G, Bang OY, Poppe AY, Montanera W, Rempel J, Eesa M, Menon BK, Demchuk AM, Goyal M, Hill MD for the ESCAPE Trial Investigators. The Future of Endovascular Treatment: Insights from the ESCAPE Investigators. Int J Stroke. 2016 Feb;11(2):156-63. (IF 3.833)
  • Puetz V, Barlinn K, Bodechtel U , Campbell B, Linn J, Gerber JC. Imaging-based selection for revascularization in acute ischemic stroke. Curr Opin Neurol. 2016 Feb;29(1):20-9. (IF: 4,469)
  • Loewenbrück KF, Liesenberg J, Dittrich M, Schäfer J , Patzner B, Trausch B, Machetanz J, Hermann A , Storch A . Nerve ultrasound in the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis with predominant lower motor neuron disease (ALS/LMND). J Neurol. 2016 Jan;263(1):35-44. (IF 3.377)
  • Kepplinger J, Prakapenia A, Barlinn K , Siegert G, Gehrisch S, Zerna C , Beyer-Westendorf J, Puetz V, Reichmann H, Siepmann T, Bodechtel U . Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol. J Thromb Thrombolysis. 2016 Feb;41(2):293-300. (IF: 1,884)
  • Paciaroni M, Agnelli G, Falocci N, Barlinn K, Pallesen LP, Kepplinger J, Bodechtel U , Gerber J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Lees KR. Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study. J Neurol. 2016 Feb;263(2):231-7. (IF: 3,408)
  • Schläger C, Körner H, Krueger M, Vidoli S, Haberl M, Mielke D, Brylla E, Issekutz T, Cabañas C, Nelson PJ, Ziemssen T , Rohde V, Bechmann I, Lodygin D, Odoardi F, Flügel A. Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid. Nature. 2016 Feb 18;530(7590):349-53.
  • Vormfelde SV, Ortler S, Ziemssen T . Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol. JMIR Res Protoc. 2016 Feb 4;5(1):e23.
  • Zerna C, Siepmann T, Barlinn K, Kepplinger J, Pallesen LP , Puetz V, Bodechtel U. Association of time on outcome after intravenous thrombolysis in the elderly in a telestroke network. J Telemed Telecare. 2016 Jan;22(1):18-24. (IF 1,377)
  • Kern R, Haase R, Eisele JC, Thomas K, Ziemssen T . Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System. Interact J Med Res. 2016 Jan 8;5(1):e2.
  • Schmitz-Peiffer H , Juratli TA, Schackert G, Reiss G, Hallmeyer-Elgner S, Krex D. Neuropsychologische Aspekte bei intrakraniellen Meningeomen. J Neurol Neurochir Psychiatr, 2016; 17 (2).

  • Schmitz-Peiffer H , Linse L, Rüger R, Joos M, Löhle M, Storch A, Hermann A. Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases [abstract]. Mov Disord. 2016; 31 (suppl 2).

2015

  • Siepmann T, Barlinn K , Penzlin AI, Illigens BM, Kitzler H, Bodechtel U . Subsequent Bilateral Hippocampal Diffusion Restriction and Atrophy in Repeated Status Epilepticus. Neurodiagn J. 2015 Dec;55(4):243-50. (IF: 0,3)
  • Ziemssen T , Sylvester L, Rametta M, Ross AP. Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™). Neurol Ther. 2015 Dec;4(2):125-36.
  • Barlinn K, Kepplinger J, Puetz V, Illigens BM, Bodechtel U, Siepmann T . Exploring the risk-factor association between depression and incident stroke: a systematic review and meta-analysis. Neuropsychiatr Dis Treat 2015 Dec 18;11:1-14. (IF 1,87)
  • Lojewski X, Srimasorn S, Rauh J, Francke S , Wobus M, Taylor V, Araúzo-Bravo MJ, Hallmeyer-Elgner S , Kirsch M, Schwarz S, Schwarz J, Storch A , Hermann A . Perivascular MSCs from the adult human brain harbour no instrinsic neuroectodermal but high mesodermal differentiation potential. Stem Cells Translational Medicine, in press (IF: 5,709)
  • Barlinn K , Seibt J, Engellandt K, Gerber J, Puetz V, Kepplinger J, Wunderlich O, Pallesen LP , Bodechtel U, Koch R, von Kummer R, Dzialowski I. Multimodal Computed Tomography Based Definition of Cerebral Imaging Profiles for Acute Stroke Reperfusion Therapy (CT-DEFINE): Results of a Prospective Observational Study. Clin Neuroradiol. 2015 Dec;25(4):403-10. (IF: 2,887)
  • Tomsick TA, Foster LD, Liebeskind DS, Hill MD, Carrozella J, Goyal M, von Kummer R, Demchuk AM, Dzialowski I, Puetz V , Jovin T, Morales H, Palesch YY, Broderick J, Khatri P, Yeatts SD; IMS III Investigators. Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial. AJNR Am J Neuroradiol. 2015 Nov;36(11):2074-81 (IF: 3,124)
  • Siepmann T , Penzlin AI, Frenz E, Barlinn K , Weidner K, Ziemssen T, Reichmann H , Illigens BM. [Sensory and autonomic small fiber neuropathy]. MMW Fortschr Med. 2015 Nov 12;157 Spec No 2:60-4. (IF: 0)
  • Guluma KZ, Liebeskind DS, Raman R, Rapp KS, Ernstrom KB, Alexandrov AV, Shahripour RB, Barlinn K , Starkman S, Grunberg ID, Hemmen TM, Meyer BC, Alexandrov AW. Feasibility and Safety of Using External Counterpulsation to Augment Cerebral Blood Flow in Acute Ischemic Stroke-The Counterpulsation to Upgrade Forward Flow in Stroke (CUFFS) Trial. J Stroke Cerebrovasc Dis. 2015 Nov;24(11):2596-604. (IF: 1,599)
  • Goyal N, Tsivgoulis G, Zand R, Sharma VK, Barlinn K , Male S, Katsanos AH, Bodechtel U , Iftikhar S, Arthur A, Elijovich L, Alexandrov AW, Alexandrov AV. Systemic thrombolysis in acute ischemic stroke patients with unruptured intracranial aneurysms. Neurology. 2015 Oct 27;85(17):1452-8. (IF: 8,116)
  • Ziemssen T . Physician-patient communication skills: e-tools. Neurodegener Dis Manag. 2015;5(6 Suppl):51-3.
  • Ziemssen T , Gilgun-Sherki Y. Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate. BMC Neurol. 2015 Oct 8;15:189.
  • Li K, Reichmann H, Ziemssen T . Recognition and treatment of autonomic disturbances in Parkinson's disease. Expert Rev Neurother. 2015 Oct;15(10):1189-203.
  • Siepmann T, Reichmann H. Diagnostic Value of Systemic Alpha-Synuclein Deposits in Parkinson’s Disease – Pro.  Akt Neurol Okt. 2015;42(08):482-484. (IF: 0)
  • Brandt MD , Brandt K, Werner A, Schoenfeld R, Loewenbrueck K , Donix M, Schaich M, Bornhaeuser M, v. Kummer R, Leplow B, Storch A .  Preventive brain radio-chemotherapy alters plasticity associated metabolite profile in the hippocampus but seems to not affect spatial memory in young leukemia patients. Brain Behav., 2015 Sep; 36(48): 3437-46 ( IF: 2.128 )
  • Ziemssen T , Rauer S, Stadelmann C, Henze T, Koehler J, Penner IK, Lang M, Poehlau D, Baier-Ebert M, Schieb H, Meuth S. Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review. PLoS One. 2015 Sep 22;10(9):e0138243.
  • Ziemssen T , De Stefano N, Pia Sormani M, Van Wijmeersch B, Wiendl H, Kieseier BC. Optimizing therapy early in multiple sclerosis: An evidence-based view. Mult Scler Relat Disord. 2015 Sep;4(5):460-9.
  • Siepmann T , Penzlin AI, Kepplinger J , Illigens BM, Weidner K, Reichmann H, Barlinn K . Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence. Brain Behav. 2015 Sep 23;5(10):e00373. (IF: 2,128)
  • Woopen H, Richter R, Chekerov R, Siepmann T, Ismaeel F, Sehouli J. The influence of comorbidity and comedication on grade III/IV toxicity and prior discontinuation of chemotherapy in recurrent ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO). Gynecol Oncol 2015 Sep;138(3):735-740.(IF 3,77)
  • Wächter N , Storch A , Hermann A . Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms. Amyotroph Lateral Scler Frontotemporal Degener. 2015, Sep 7;16(7-8):431-41. (IF: 2,677)
  • Paciaroni M, Agnelli G, Falocci N,… Barlinn K, Pallesen LP, Kepplinger J, Bodechtel U, Gerber J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Mosconi MG, Bubba V, Silvestri I, Lees KR. Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study. Stroke. 2015 Aug;46(8):2175-82. (IF:5,723)
  • Seidlitz A, Siepmann T , Löck S, Juratli T, Baumann M, Krause M. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.Radiat Oncol 2015 Aug:10:172. (IF 2,47)
  • Siepmann T, Kepplinger J, Zerna C, Schatz U, Penzlin AI, Pallesen LP , Illigens BM, Weidner K, Reichmann H, Puetz V, Bodechtel U, Barlinn K . The Effects of Pretreatment versus De Novo Treatment with Selective Serotonin Reuptake Inhibitors on Short-term Outcome after Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2015 Aug;24(8):1886-92. (IF: 1,599)
  • Japtok, J ., Lojewksi, X. , Naumann, M ., Klingenstein, M., Reinhardt, P., Sterneckert, J., Putz, S., Demestre, M., Boeckers, T.M., Ludolph, A.C., Liebau, S., Storch, A ., Hermann, A. *,. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging. Neurobiol. Dis. 2015, Aug 15; (82) 420–429; (IF 4,856) *corresponding author
  • Japtok J, Lojewksi X, Naumann M , Klingenstein M, Reinhardt P, Sterneckert J, Putz S, Demestre M, Boeckers TM, Ludolph AC, Liebau S, Storch A , Hermann A . Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging. Neurobiol Dis. 2015 Aug 4. pii: S0969-9961(15)30021-8. (IF: 5,078)
  • Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, […] Barlinn K, Pallesen LP , Kepplinger J, Bodechtel U, Gerber J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Mosconi MG, Bubba V, Silvestri I, Lees KR.  Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study. Stroke. 2015 Aug;46(8):2175-82 (IF 5,787)
  • Waechter N, Storch A, Hermann A . Human TDP43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell autonomous mechanisms. Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jul 15:1-11. (IF: 2,591)
  • Reimann M , Weiss N, Vilser W, Ziemssen T . Local endothelial dysfunction does not affect global endothelial function. Vasa. 2015 Jul;44(4):277-84.
  • Siepmann T , Penzlin AI, Bodechtel U . Stroke in the Young – Etiology, Diagnosis and Treatment T. Akt Neurol 2015 Jun;42:279-290. (IF:0)
  • Hermann A , Reuner U, Schaefer J , Fathinia P, Leimert T, Kassubek J, Leimert M, Ludolph AC, Storch A, 2015, The diagnostic value of midbrain hyperechogenicity in ALS is limited for discriminating key ALS differential diagnoses, BMC Neurol. 15 : 33 (IF: 2,486)
  • Zerna C, von Kummer R, Gerber J, Engellandt K, Abramyuk A, Wojciechowski C, Barlinn K, Kepplinger J, Pallesen LP , Siepmann T, Dzialowski I, Reichmann H, Puetz V, Bodechtel U. Telemedical Brain Computed Tomography Misinterpretation by Stroke Neurologists Is Not Associated with Thrombolysis-Related Intracranial Hemorrhage. J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1520-6. (IF: 1,599)
  • Zerna C , Guenther M, Folprecht G, Puetz V . Acute ischemic stroke and myocardial infarction after chemotherapy with vinorelbine for non-small cell lung cancer: a case report. J Chemother. 2016 Jul 22:1-5. (IF 0.330)
  • Schurig K , Zieris A, Hermann A , Freudenberg U, Heidel S, Grimmer M, Storch A , Werner C. Neurotropic growth factors and glycosaminoglycan based matrices to induce dopaminergic tissue formation. Biomaterials. 2015 Jul 21;67:205-213 (IF: 8,557)
  • Choi EY, Lim JH, Neuwirth A, Economopoulou M, Chatzigeorgiou A, Chung KJ, Bittner S, Lee SH, Langer H, Samus M, Kim H, Cho GS, Ziemssen T , Bdeir K, Chavakis E, Koh JY, Boon L, Hosur K, Bornstein SR, Meuth SG, Hajishengallis G, Chavakis T. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination. Mol Psychiatry. 2015 Jul;20(7):880-8.
  • Ziemssen T, Kern R , Cornelissen C. The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice. BMC Neurol. 2015 Jun 18;15:93.
  • Pallesen LP , Gerber J, Dzialowski I, van der Hoeven EJ, Michel P, Pfefferkorn T, Ozdoba C, Kappelle LJ, Wiedemann B, Khomenko A, Algra A, Hill MD, von Kummer R, Demchuk AM, Schonewille WJ*, Puetz V* . Diagnostic and Prognostic Impact of pc-ASPECTS Applied to Perfusion CT in the Basilar Artery International Cooperation Study. BASICS Study Group. J Neuroimaging. 2015 May-Jun;25(3):384-9 (IF 1,625) *contributed equally
  • Georgiadis AL, Palesch YY, Zygun D, Hemphill JC 3rd, Robertson CS, Leroux PD, Suarez JI; Second Neurocritical Care Research Conference Investigators ( Schneider H ). Multi-modality neuro-monitoring: conventional clinical trial design. Neurocrit Care . 2015 Jun;22(3):369-77. (IF: 2.488)
  • Lazaridis C, Maas AI, Souter MJ, Martin RH, Chesnut RM, DeSantis SM, Sung G, Leroux PD, Suarez JI; Second Neurocritical Care Research Conference Investigators ( Schneider H ). Alternative clinical trial design in neurocritical care. Neurocrit Care . 2015 Jun;22(3):378-84. (IF: 2.488)
  • Reimann M , Vilser W, Gruber M, Bornstein SR, Ziemssen T . Insulin is a key determinant of elevated retinal arteriolar flicker response in insulin-resistant individuals. Diabetologia. 2015 Sep;58(9):2154-60.
  • Hermann A , Reuner U, Schaefer J , Leimert T, Storch A . Width of 3rd ventricle determined by brain stem sonography does not distinguish bulbar motor syndromes. Amyotroph Lateral Scler Frontotemporal Degener May 16:1-3 (IF: 2,591)
  • Hohenstein B, Passauer J, Ziemssen T , Julius U. Immunoadsorption with regenerating systems in neurological disorders --A single center experience. Atheroscler Suppl. 2015 May;18:119-23.
  • Reimann M, Rüdiger H , Weiss N, Ziemssen T . Acute hyperlipidemia but not hyperhomocysteinemia impairs reflex regulation of the cardiovascular system. Atheroscler Suppl. 2015 May;18:8-15.
  • Reimann M , Weiss N, Ziemssen T . Different responses of the retinal and cutaneous microcirculation to transient dysmetabolic conditions. Atheroscler Suppl. 2015 May;18:1-7.
  • Christoph M, Herold J, Berg-Holldack A, Rauwolf T, Ziemssen T , Schmeisser A,  Weinert S, Ebner B, Said S, Strasser RH, Braun-Dullaeus RC. Effects of the PPARγ agonist pioglitazone on coronary atherosclerotic plaque composition and plaque progression in non-diabetic patients: a double-center, randomized controlled VH-IVUS pilot-trial. Heart Vessels. 2015 May;30(3):286-95.
  • Schatz U, Illigens BM, Siepmann T , Arneth B, Siegert G, Siegels D, Heigl F, Hettich R, Ramlow W, Prophet H, Bornstein SR, Julius U. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients – A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose. Atheroscler Suppl. 2015 May;18:199-208. (IF 3,36)
  • Maetzler W, Karam M, Berger MF, Heger T, Maetzler C, Ruediger H , Bronzova J, Lobo PP, Ferreira JJ, Ziemssen T , Berg D. Time- and frequency-domain parametersof heart rate variability and sympathetic skin response in Parkinson's disease. J Neural Transm (Vienna). 2015 Mar;122(3):419-25.
  • Meyer AK, Sampathkumar C, Fransecky L, Maisel M, Kißenkötter S, Weselek G, Berndt S , Kirsch M, Schwarz J, Hermann A , Storch A , 2015, Neural stem cell culture model for LRRK2 function determines regulation of dopaminergic and microtubule-associated genes, Basal Ganglia 5: 71–76 (IF: not available yet)
  • Honisch S, Gu S, Vom Hagen JM, Alkahtani S, Al Kahtane AA, Tsapara A, Hermann A , Storch A , Schöls L, Lang F, Stournaras C. Chorein Sensitive Arrangement of Cytoskeletal Architecture. Cell Physiol Biochem. 2015;37(1):399-408. (IF 2.875)
  • Barlinn K , Lehrach H, Siepmann T , Braeuer D, Buntrock U, Sassim N. Temporary loss of moral behavior in a patient undergoing chemotherapy with cisplatin - breaking bad. BMC Psychiatry. 2015 Feb 5;15:9. (IF: 2,576)
  • Paciaroni M, Inzitari D, Agnelli G, […], Barlinn K, Kepplinger J, Bodechtel U , Gerber J, Bovi P, Cappellari M, […], Toni D. Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study. J Neurol. 2015 Feb;262(2):459-68. (IF: 3,408)
  • Kuramatsu JB, Gerner ST, Schellinger PD, Glahn J, Endres M, Sobesky J, Flechsenhar J, Neugebauer H, Jüttler E, Grau A, Palm F, Röther J, Michels P, Hamann GF, Hüwel J, Hagemann G, Barber B, Terborg C, Trostdorf F, Bäzner H, Roth A, Wöhrle J, Keller M, Schwarz M, Reimann G, Volkmann J, Müllges W, Kraft P, Classen J, Hobohm C, Horn M, Milewski A, Reichmann H, Schneider H, Schimmel E , Fink GR, Dohmen C, Stetefeld H,Witte O, Günther A, Neumann-Haefelin T, Racs AE, Nueckel M,Erbguth F, Kloska SP, Dörfler A, Köhrmann M, Schwab S, Huttner HB. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA . 2015 Feb 24;313(8):824-36.(IF 35.289)
  • Christoph M, Herold J, Berg-Holldack A, Rauwolf T, Ziemssen T , Schmeisser A, Weinert S, Ebner B, Ibrahim K, Strasser RH, Braun-Dullaeus RC. Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone on Peripheral Vessel Function and Clinical Parameters in Nondiabetic Patients: A Double-Center, Randomized Controlled Pilot Trial. Cardiology. 2015;131(3):165-71.
  • Barlinn K , Kolieskova S, Shahripour RB, Kepplinger J , Boehme AK, Siepmann T, Puetz V, Bodechtel U , Jordan WD, Alexandrov AV. Increased pulsatility of the intracranial blood flow spectral waveform on transcranial Doppler does not point to peripheral arterial disease in stroke patients. J Stroke Cerebrovasc Dis. 2015 Jan;24(1):189-95. (IF: 1,599)
  • Ziemssen F, Ziemssen T , Brandt AU, Lagrèze WA. Dynamic formation of macular microcysts independent of vitreous traction changes. Neurology. 2015 Jan 27;84(4):436-7.
  • Tsourdi E, Gruber M, Rauner M, Blankenburg J, Ziemssen T , Hofbauer LC. Graves' disease after treatment with alemtuzumab for multiple sclerosis. Hormones(Athens). 2015 Jan-Mar;14(1):148-53.
  • Giovannoni G, de Jong B, Derfuss T, Izquierdo G, Mazibrada G, Molyneux P, Nicholas R, Overell J, Ziemssen T , Juliusson G. A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe. Mult Scler Relat Disord. 2015 Jan;4(1):83-4.
  • Smith AJ, Malan L, Uys AS, Malan NT, Harvey BH, Ziemssen T . Attenuated brain-derived neurotrophic factor and hypertrophic remodelling: the SABPA study. J Hum Hypertens. 2015 Jan;29(1):33-9.
  • Karkoska A, Hallmeyer-Elgner S, Berth H, Reichmann H, Schmitz-Peiffer H . Improving the assessment of everyday cognitive functioning in patients with epilepsy by means of proxy reports. Epilepsy Behav, 2015. 44C: 55-58.

  • Schmitz-Peiffer H , Reichmann H, Hallmeyer-Elgner S. Epilepsie und Aufmerksamkeit – ein Vergleich zwischen EpiTrack® und der Testbatterie zur Aufmerksamkeitsprüfung (TAP). Zeitschrift für Epileptologie; 2015, 28, Supplement 1– p83.

2014

  • Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, de Sá JC, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y. A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial. J Neurol. 2014 Nov;261(11):2101-11.
  • Kern S , Rohleder N, Eisenhofer G, Lange J, Ziemssen T . Time matters – acute stress response and glucocorticoid sensitivity in early multiple sclerosis. Brain Behav Immun. 2014 Oct;41:82-9.
  • Siepmann T, Illigens BM, Reichmann H, Ziemssen T . [Axon-reflex based nerve fiber function assessment in the detection of autonomic neuropathy]. Nervenarzt. 2014 Oct;85(10):1309-14.
  • Thomas K , Dietze K, Wehner R, Metz I, Tumani H, Schultheiß T , Günther C, Schäkel K, Reichmann H , Brück W, Schmitz M, Ziemssen T . Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2014 Sep 18;1(3):e33.
  • Prestel J, Volkers P, Mentzer D, Lehmann HC, Hartung HP, Keller-Stanislawski B; GBS Study Group ( Schneider H ). Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf . 2014 Nov;23(11):1192-204.
  • Günther R , Saal KA, Suhr M, Scheer D, Koch JC, Bähr M, Lingor P, Tönges L. The rho kinase inhibitor Y-27632 improves motor performance in male SOD1(G93A) mice. Front Neurosci. 2014 Oct 7;8:304. doi: 10.3389/fnins.2014.00304.

  • Uys AS, Malan L, van Rooyen JM, Steyn HS, Reimann M, Ziemssen T . Attenuated NOx responses and myocardial ischemia, a possible risk for structural vascular disease in African men: the SABPA study. J Hum Hypertens. 2014 Jul;28(7):438-43.
  • Thomas K , Schrötter H, Halank M, Ziemssen T . Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease. BMC Neurol. 2014 Jun 7;14:126.
  • Jüttler E, Unterberg A, Woitzik J, Bösel J, Amiri H, Sakowitz OW, Gondan M, Schiller P, Limprecht R, Luntz S, Schneider H , Pinzer T, Hobohm C, Meixensberger J, Hacke W; DESTINY II Investigators. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke . N Engl J Med . 2014 Mar 20;370(12):1091-100. (IF 55.873)
  • Pamporaki C, Bursztyn M, Reimann M, Ziemssen T , Bornstein SR, Sweep FC, Timmers H, Lenders JW, Eisenhofer G. Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma. Eur J Endocrinol. 2014 Feb 4;170(3):349-57.
  • Tönges L, Günther R , Suhr M, Jansen J, Balck A, Saal KA, Barski E, Nientied T, Götz AA, Koch JC, Mueller BK, Weishaupt JH, Sereda MW, Hanisch UK, Bähr M, Lingor P. Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia. 2014 Feb;62(2):217-32. doi: 10.1002/glia.22601.

2013

  • Reimann M , Lohmann T, Ziemssen T . [Stress-cardiomyopathy--a psychological phenomenon?]. MMW Fortschr Med. 2013 Nov 21;155(20):41-3.
  • Neugebauer H, Kollmar R, Niesen WD, Bösel J, Schneider H , Hobohm C, Zweckberger K, Heuschmann PU, Schellinger PD, Jüttler E; DEPTH-SOS Study Group; IGNITE Study Group. DEcompressive surgery Plus hypoTHermia for Space-Occupying Stroke (DEPTH-SOS): a protocol of a multicenter randomized controlled clinical trial and a literature review . Int J Stroke . 2013 Jul;8(5):383-7.